Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional)

The summary for the Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional): Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to establish collaborations between liver cancer investigators and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-funded Liver Cirrhosis Network (LCN) members to advance our understanding of hepatocellular carcinoma (HCC) as the result of liver cirrhosis and its etiologic risks, development, progression, early diagnosis, and treatment. The funds available through this FOA will support new multidisciplinary liver cancer-specific collaborations between eligible liver cancer investigators and one or more of the NIDDK-funded LCN members. This structure is intended to maximize the effectiveness of the network by facilitating collaborative opportunities that enhance the scientific goals of the collaborating units and the LCN as a whole. Applicants selected for NCI funding will become members of the Liver Cirrhosis Network-Liver Cancer Collaboratory (LCN-LCa) Committee.

Federal Grant Title:	Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-CA-23-023
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.396
CFDA Descriptions:	Information not provided
Current Application Deadline:	June 2nd, 2023
Original Application Deadline:	June 2nd, 2023
Posted Date:	March 30th, 2023
Creation Date:	March 30th, 2023
Archive Date:	July 8th, 2023
Total Program Funding:
Maximum Federal Grant Award:	$200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	March 30th, 2023

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-023.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Opt...; • Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allow...; • Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Tr...; • Advancing Cancer Control Equity Research through Transformative Solutions Coordination Cen...; • Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional...; • Mouse Models of Human Cancers Consortium; • Integrative Cancer Biology Programs; • Memory T Lymphocytes in Cancer Immunology (R21)
More Grants from the National Institutes of Health: • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)